Adipose tissue is the source of production and site of action of several pro-and antiinflammatory cytokines. We have recently shown that white adipose tissue (WAT) is a major producer of the antiinflammatory IL-1 receptor antagonist (IL1Ra). Because IL-1Ra serum levels are elevated 7-fold in human obesity and an excess of this protein has been implicated in the acquired resistance to leptin and insulin, we investigated the regulation of IL-1Ra in human WAT.
A DIPOSE TISSUE IS not only a storage organ for excess calories, but it has also emerged as an important source of secreted factors, such as leptin, adiponectin, resistin, and certain cytokines and chemokines, including TNF-␣, IL-6, and, more recently, IL-1 receptor antagonist (IL-1Ra) (1) (2) (3) . These factors are speculated to have local and systemic metabolic actions, e.g. by modulating insulin sensitivity, but also to contribute to cardiovascular complications that are closely linked to obesity (2, 4 -6) .
We have recently shown that human and rodent white adipose tissue (WAT) is a major source of IL-1Ra, which is a member of the IL-1 family inhibiting the binding of IL-1␣ and IL-1␤ to their receptor (3) . The relevance of this observation in vivo is substantiated by the observation that the serum levels of IL-1Ra are markedly increased in obese patients and in patients with Cushing's syndrome, correlating with body mass index (BMI) and the degree of insulin resistance (7, 8) . The serum levels of IL-1Ra observed in obese patients are similar to those in patients with autoimmune inflammatory disorders or sepsis, suggesting that IL-1Ra may have immunomodulatory and/or metabolic activities in these patients. Indeed, it has not only been suggested that IL-1Ra may represent a link between obesity and an acquired resistance to leptin at the hypothalamic level (7, 9) , but recent data demonstrate a metabolic role of IL-1Ra in the periphery for the control of fat mass and insulin sensitivity (6) (Somm, E., and C. A. Meier, unpublished data).
Because adipose tissue produces much more IL-1Ra than TNF-␣ and IL-6 (3) and because IL-1 and IL-1Ra are involved in: 1) the regulation of lipid metabolism in vivo (6, 10) and in vitro (10 -13) ; 2) the control of adipocyte differentiation (14, 15) ; and 3) the regulation of glucose uptake (16) , we now define the cellular source as well as the regulators of IL-1Ra in human adipose tissue.
We show that adipocytes and stromal cells secrete IL-1Ra and that IL-1␣, IL-1␤, and interferon (IFN)-␤ are stimulators of IL-1Ra production. The observation that some of these factors are also produced by WAT indicates the presence of a novel paracrine signaling network in human adipose tissue.
Materials and Methods Materials
IL-1Ra and IL-1␤ concentrations in the supernatant of WAT cultures were determined by the Quantikine ELISA (R&D Systems Europe Ltd., Abingdon, UK) and Immunotech (Marseille, France) kits, respectively, whereas IFN-␤ and IL-10 concentrations were measured with the kits from Biosource (Lucerna Chem AG, Luzern, Switzerland). Recombinant human IL-1␣ and -␤ and TNF-␣ were a kind gift of Biogene (Boston, MA), and IFN-␤ was provided by Ares-Serono (Rehovot, Israel). IL-4 was a kind gift of Christophe Caux (Schering-Plough, Dardilly, France). Recombinant murine leptin and IL-10 were from Peprotech (Juro, Luzern, Switzerland), and IL-6 was from R&D Systems.
Culture and analysis of human adipose tissue
Authorizations from the Ethical Commission of the University Hospitals of Geneva and the Centre Hospitalier Universitaire Vaudois were obtained for this study, including the informed consent from the patients.
For the analysis of cytokine expression and production, sc and visceral adipose tissue samples were obtained from 28 morbidly obese patients with a median BMI of 45 kg/m 2 (range, 37-65 kg/m 2 ) without comorbidity, undergoing gastric banding or gastric bypass surgery. Subcutaneous adipose tissue samples were also obtained from 10 patients with a BMI of less than 30 kg/m 2 . Tissues were immediately frozen in liquid nitrogen before the preparation of tissue extracts and RNA.
For short-term culture experiments, human sc WAT was obtained from patients undergoing plastic surgery and prepared as described (3, 17) . Briefly, tissue was placed in PBS [prewarmed at 37 C, containing penicillin (100 U/ml) and streptomycin (100 mg/ml)], and connective tissue and blood vessels were removed by dissection before mincing the tissue into 5-to 10-mg pieces. Minced tissue fragments were filtered through nylon mesh (350 m) and washed with medium [M199, supplemented with 5% fetal bovine serum (FBS), penicillin, and streptomycin]. A total of 0.3 g of minced tissue were then placed into 1 ml M199 (with 5% FBS, penicillin, and streptomycin) for 18 h before stimulation with the appropriate compounds for 48 h. At the end of the stimulation period, supernatants were collected for cytokine determination, and the explants were recovered and placed directly into TRIzol reagent (Invitrogen, Basel, Switzerland) for immediate RNA preparation.
Preparation and culture of stromal fraction and adipocytes from human WAT
Minced human adipose tissue fragments were first digested with collagenase type I (200 U/ml; Worthington Biochemical Corp., Lakewood, NJ) (3 ml/g adipose tissue) in low-glucose (1000 mg/liter) DMEM containing penicillin and streptomycin, as well as the BSA fraction V (20 mg/ml) (Sigma, Buchs, Switzerland) at 37 C in a rocking bath. After 30 min of incubation, the digestion was stopped by the addition of FBS (0.3 ml/ml digestion medium). Adipocytes and the stromal fraction were then separated from undigested tissue by filtration through a 350-m nylon mesh before the separating centrifugation (10 min at 200 ϫ g). Adipocytes prepared from 0.6 g of adipose tissue were resuspended in 2 ml of low-glucose DMEM (10% FBS, glutamine 200 mm, and 1% penicillin and streptomycin). The pellet of the stromal fraction was resuspended in low-glucose DMEM containing 10% FBS, 1% glutamine, and 1% penicillin and streptomycin to promote cell adhesion. Twentyfour hours after plating, the medium was changed, and cells were grown for 4 d before stimulation with the appropriate compounds for another 48 h.
Preparation and quantification of DNA and RNA
Total DNA and RNA from 500 mg of human sc or visceral WAT, as well as from the cultured explants, were prepared using the TRIzol reagent (Invitrogen) according to the manufacturer's instructions. DNA was measured with the PicoGreen Kit (Molecular Probe, Juro, Luzern, Switzerland). Total RNA (5 g) was reverse-transcribed using 800 U Moloney murine leukemia virus reverse transcriptase (Invitrogen) in the presence of 0.3 U/l RNAsin (Promega Corp., Madison, WI), 7.5 m of random primers [oligo(dN)6], 1.2 mm of deoxynucleotide triphosphate, and 12 m of dithiothreitol.
The expression of RNAs for human secreted IL-1Ra, IL-1␣, IL-1␤, IL-1 receptor type I (IL-1RI), IL-1 receptor type II (IL-1RII), IL-1 receptorassociated protein (IL-1RAcP), IFN-␣ and -␤ receptor subunits 1 and 2 (IFNAR1 and IFNAR2), and 28S was determined by quantitative realtime PCR using a LightCycler (Roche Diagnostics, Basel, Switzerland) with the DNA Master SYBR Green I or Fast Start DNA Master SYBR Green I (Roche Molecular Biochemicals, Rotkreuz, Switzerland) kits as appropriate. The primers used were as follows: for IL-1Ra, sense 5Ј-tccgcagtcacctaatcactc-3Ј, antisense 5Ј-ttgacacaggacaggacaat-3Ј; IL-1␣, sense 5Ј gtaagctatggcccactcca-3Ј, antisense 5Ј-aggtgctgacctaggcttga-3Ј; IL-1␤, sense 5Ј-gctgaggaagatgctggttc-3Ј, antisense 5Ј-gtgatcgtacaggtgcatcg-3Ј; IL-1RI, sense 5Ј-aaactacccgttgcaggaga-3Ј, antisense 5Ј-cacattcatcacgatgagcc-3Ј; IL-1RII, sense 5Ј-gcgcttgtacgtgttggtaa-3Ј, antisense 5Ј-acagaggcccacaaccagta-3Ј; IL-1RacP, sense 5Ј-ctgcaaagtgatgcctcaga-3Ј, antisense 5Ј-cggtcctgcctagtccaata-3Ј; IFNAR1, sense 5Ј-atcggtgctccaaaacagtc-3Ј, antisense 5Ј-gtgctctggctttcacacaa-3Ј; and IFNAR2, sense 5Ј-cccttaaaatgcaccctcct-3Ј, antisense 5Ј-tcaagactttggggaggcta-3Ј.
Statistics
Results are expressed as means Ϯ 1 sem. The nonparametric MannWhitney U test was used for comparing the effects of the various stimuli (SYSTAT 10.01; SPSS, Inc., Chicago, IL) and comparison among tissues.
Results

IL-1Ra is mostly secreted by the adipocyte fraction of human adipose tissue
We have previously shown that human adipose tissue expresses and secretes IL-1Ra, but it remained unclear whether the adipose and/or stromal fractions were the main source. As shown in Fig. 1 , the adipose and stromal fractions both secreted IL-1Ra, with adipocytes producing 1.9-fold more IL-1Ra when normalized for DNA content. However, when normalized for the initial tissue mass used for cell fractionation, adipocytes account for about 95% of the production of IL-1Ra (18-fold higher production compared with the stromal fraction), and the stromal fraction accounts for 5% of the production of IL-1Ra.
IL-1Ra is induced by IL-1 and IFN-␤ in primary cultures of human adipose tissue
To examine which factors might regulate the production of IL-1Ra in WAT, we tested several candidate agents, such as phorbol myristate acetate (PMA), lipopolysaccharide (LPS), dexamethasone, and certain cytokines (Fig. 2) . PMA and LPS enhanced the expression and secretion of IL-Ra 2.4 Ϯ 0.2-fold and 4.6 Ϯ 1-fold, respectively, whereas dexamethasone was a strong inhibitor of basal IL-1Ra production. IL-1␣ and ␤, as well as IFN-␤, the fibroblast-derived form of IFN, all induced IL-1Ra production, the latter more than 35-fold. However, IL-6 and TNF-␣, both of which were previously shown to be produced by WAT, did not regulate IL-1Ra. Similarly, leptin, which we have previously shown to stimulate IL-1Ra secretion in monocytes, had no effect on IL-1Ra production in WAT (18) .
IFN-␤ induces IL-1Ra in a dose-and timedependent manner
IFN-␤ is not only a known regulator of IL-1Ra in monocytes, but it also up-regulates IL-1Ra in human WAT (3). IFN-␤ stimulated the secretion of IL-1Ra in a dose-dependent manner with a maximal effect at a concentration of 2000 U/ml (Fig. 3A) , and this response could already be observed at 8 h (Fig. 3B) . Moreover, we assessed whether the stimulatory effect of IFN-␤ on IL-1Ra can be observed on the isolated adipose and stromal fractions of WAT, which was the case as shown in Fig. 3C .
Moreover, we found the IFN-␣/␤ receptor subunits IF-NAR1 and IFNAR2 to be expressed in human adipose tissue, with higher levels of IFNAR2 being present in the sc and visceral WAT from obese patients (Fig. 3D) . However, although the expression of IFN-␤ has been recently described in adipose tissue (19) where it correlated with the body mass, we were unable to reliably detect IFN-␤ protein in supernatant of human WAT explants. This is possibly due to the limited sensitivity of the currently available assays, as well as the rapid degradation of the secreted IFN-␤ by the producing cells (Chicheportiche, R., and J.-M. Dayer, personal communication).
IL-1 induces IL-1Ra in a dose-and time-dependent manner
Similar to IFN-␤, IL-1␣ and IL-1␤ also induced the secretion of IL-1Ra by WAT explants. Because we have shown previously that IL-1␤ is produced by human WAT (3), we examined the dose-response curve as well as the time course of the regulatory effects of IL-1␣ and ␤ on IL-1Ra secretion by human WAT explants. A maximal effect was observed between 500 and 1000 pg/ml for both isoforms of IL-1, with a rapid effect within the first 8 h (Fig. 4, A and B) . To exclude that IL-1 and IFN-␤ regulated IL-1Ra through their mutual induction, we measured the production of IFN-␤ after treatment of WAT explants with IL-1 for 48 h and vice versa with no measurable effect (data not shown), suggesting that the production of IL-1Ra is independently regulated by these two cytokines.
Although certain metabolic effects of IL-1 on WAT have been described previously, it was unknown whether this tissue expresses IL-1 receptors. Therefore, we measured the expression of the different components of IL-1 signaling in sc and visceral adipose tissue from nonobese and obese patients (Fig. 4C) . Indeed, human WAT expressed the functional type I receptor for IL-1 and the decoy IL-1RII, as well as the IL-1RAcP, which is important for signaling through the IL-1RI. IL-1Ra and IL-1RI were markedly up-regulated more than 9-fold and 3-fold, respectively, in WAT from obese patients. This increase was not accompanied by a concomitant higher expression of IL-1RII and IL-1RAcP. Furthermore, IL-1␤ expression was selectively increased in the visceral fat from obese subjects.
Because IL-1 and the IL-1 receptor genes were up-regulated in obese subjects, we examined the regulation of these genes in human WAT ex vivo. WAT explants were treated for 48 h with PMA (25 nm) or LPS (5 g/ml). As can be seen in Fig. 4D , treatment with neither compound up-regulated the expression of the IL-1RI or the IL-1RAcP, whereas IL-1␤ was strongly induced by LPS, which is in keeping with an earlier observations (20) . The decoy receptor IL-1RII is expressed at low levels in adipose tissue and its expression is undetectable in cultured explants either in the basal state or after stimulation by PMA or LPS (Fig. 4D) .
IL-4 augments the secretion of IL-1Ra in WAT
As demonstrated above, IL-1 and IFN-␤ are novel regulators of IL-1Ra in human WAT. To extend these observations, we assessed the effect of other putative coregulators on the stimulatory action of IL-1␣ and ␤ on IL-1Ra secretion by WAT. Given our findings described above with regard to IFN-␤ as well as the known modulatory effects of IL-10 and IL-4 on IL-1Ra production by monocytes (21, 22) , we tested the effect of these factors on human adipose tissue cultured for 48 h. Although we used a submaximal dose of IFN-␤ (1000 U/ml), no additional effect of IL-1␣ or ␤ was seen on the stimulation by IFN-␤ (Fig. 5) . In contrast, the addition of IL-4 augmented the stimulatory effect of IL-1 1.9-fold, whereas neither IL-4 nor IL-10 was able to induce the production of IL-1Ra when used alone. (25 nM), LPS (100 ng/ml), IL-1␣ (500 pg/ml), IL-1␤ (500 pg/ml), IFN-␤ (10,000 U/ml), TNF-␣ (5 ng/ml), IL-6 (10 ng/ml), leptin (Lep; 625 nM), dexamethasone (Dex; 1 M), or control medium (Med). After 48 h of stimulation, supernatant was removed for IL-1Ra determination, and explants were collected for RNA preparation. IL-1Ra mRNA (gray bars) was determined by real-time RT-PCR corrected for 28S RNA, and IL-1Ra secretion (black bars) was determined by ELISA and expressed relative to the control level (medium) of each experiment. The bars represent the mean Ϯ 1 SEM of two to five experiments performed in triplicate. *, P Ͻ 0.05 compared with control (Med) condition. nd, Not done.
Discussion
It is now accepted that adipose tissue not only serves as the storage for excess calories, but that it also has important secretory functions. Although leptin, adiponectin, and resistin are peptides secreted by adipose tissue with known metabolic actions, WAT also secretes a number of cytokines and chemokines, such as TNF-␣ and IL-6. However, although these two proinflammatory cytokines have been speculated to contribute to insulin resistance and vascular complications, their serum levels are only marginally elevated in human obesity (5, 23, 24) . In contrast, we have recently shown that IL-1Ra serum levels are highly elevated in human obesity to a degree that is similar to that present in systemic inflammation (7) . Moreover, we have provided evidence that adipose tissue is the main source of this antiinflammatory cytokine in humans as well as rodents (3) . We now demonstrate that IL-1 is produced by adipose tissue and regulates the secretion of IL-1Ra, with IFN-␤ being another strong stimulator of IL-1Ra in WAT.
Although TNF-␣ and IL-6 were reported to be mainly produced by the stromal fraction of adipose tissue, we show that adipocytes are the main producers of IL-1Ra. Furthermore, IL-1 induces the production of IL-1Ra in a time-and dose-dependent manner, and this is compatible with a direct regulatory effect on the IL-1Ra gene, as is the case in mono- cytic cells (25) . These findings are compatible with an autocrine/paracrine regulatory loop, because: 1) we have previously shown that IL-1␤ is present in human WAT at quantities of around 6 -8 pg/mg tissue (3), and 2) we now report that the various genes involved in IL-1 receptor signaling are expressed in human WAT. Moreover, the expression of not only IL-1Ra but also of IL-1␤ and the IL-1RI are markedly increased in adipose tissue from obese subjects, suggesting that the augmented secretion of IL-1, as well as an increased sensitivity to this cytokine, might contribute to the overproduction of IL-1Ra in the obese state.
IFN-␤ strongly up-regulates IL-1Ra expression in WAT ex vivo, and IFN-␣ and -␥ showed no effect (data not shown). Recently published data from microarray experiments with WAT show that the expression of IFN-␤ and IL-1Ra are positively correlated with body mass in rodents, suggesting the presence of a local autocrine/paracrine regulation of IL-1Ra not only by IL-1 but also by IFN-␤ (19). Although IL-1 and IFN-␤ are positive regulators of IL-1Ra by themselves, we found that IL-4 can increase the stimulation of IL-1 further. Because IL-10 was described to be increased in the serum of obese patients (26) and to increase IL-1Ra production in monocytes, it was tempting to speculate that elevated amounts of IL-1Ra in the serum of obese patients might in part be due to the elevated IL-10 levels. However, our data obtained with human WAT ex vivo do not support this hypothesis.
Although WAT is clearly an important source of pro-and antiinflammatory cytokines, their true (patho)physiological role has only recently become more apparent, and it appears likely that IL-1Ra can negatively interfere with the anorexigenic activities of IL-1 at the hypothalamic and peripheral level. Specifically, IL-1 was shown to be involved in: 1) mediating some of the inhibitory effects of leptin on appetite as well as the stimulating effects on body temperature (9); and 2) inhibiting adipogenesis in vitro (11, 12) . We and others have shown that this effect can be overcome by the administration of IL-1Ra (Ref. 9 and Juge-Aubry, C. E., and C. A. Meier, unpublished data) resulting in the promotion of adipogenesis and obesity. Finally, very recent data in IL-1Ra knockout mice have shown the impaired accumulation of fat in these animals, as well as a resistance to obesity after hypothalamic lesion (6), both of which are compatible with an obesity-promoting role of IL-1Ra. Moreover, IL-4 was shown to counteract the lipolytic activity of LPS on the perilymph node adipose tissue by an unknown mechanism (27) , and we could postulate that this effect might be mediated through the locally induced production of IL-1Ra.
In summary, IL-1Ra is an antiinflammatory cytokine that is markedly up-regulated in human obesity, and the recent animal knockout studies support our concept of IL-1Ra being a promoter of obesity (6) . We now show that IL-1Ra is mainly produced by human adipocytes, rather than the stromal fraction, and that it is up-regulated by IL-1␤, IFN-␤, and IL-4.
Because human WAT expresses the receptors for IL-1 as well as for IFN-␣/␤, it will be of interest to elucidate whether these cytokines have additional regulatory effects on adipose tissue contributing to some of the metabolic and vascular complications related to obesity.
